HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ashley D Otter Selected Research

Vaccines

1/2024Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort.
11/2023Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study.
10/2023COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study.
9/2023Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.
9/2023CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study.
1/2022Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
1/2022Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups.
1/2022Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
11/2021Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner.
4/2021Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ashley D Otter Research Topics

Disease

11Infections
01/2024 - 01/2021
10COVID-19
01/2024 - 01/2021
1Smallpox (Variola)
09/2023
1Breakthrough Infections
09/2023
1Severe Acute Respiratory Syndrome
01/2021
1Asymptomatic Infections
01/2021
1Reinfection
01/2021

Drug/Important Bio-Agent (IBA)

11VaccinesIBA
01/2024 - 01/2021
4AntibodiesIBA
09/2023 - 01/2021
3BNT162 VaccineIBA
01/2022 - 04/2021
2COVID-19 VaccinesIBA
10/2023 - 04/2023
2Messenger RNA (mRNA)IBA
09/2023 - 01/2022
2AntigensIBA
09/2023 - 01/2022
2Neutralizing AntibodiesIBA
11/2021 - 04/2021
13- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA
09/2023
1smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA
09/2023
1Smallpox Vaccine (Vaccine, Smallpox)FDA Link
09/2023
1Peptides (Polypeptides)IBA
09/2023
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2023
1Immunoglobulin G (IgG)IBA
09/2023
1Interferon-gamma (Interferon, gamma)IBA
09/2023
1NucleoproteinsIBA
01/2023
1Ad26COVS1IBA
11/2021
1mRNA VaccinesIBA
04/2021
1Biomarkers (Surrogate Marker)IBA
01/2021